Tempest Therapeutics, Inc.
TPST
Amendment
Ownership
4.80%
Total Shares
2,118,644
Issuer CIK
1544227
CUSIP
87978U108
Event Date
Nov 11, 2024
Accepted
Feb 11, 2025, 05:58 PM
SEC EDGARView Original Filing
Reporting Persons (9)
Joint Filing
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Versant Vantage II, L.P. | Partnership | 4.80% | 2,118,644 | 2,118,644 | 0 |
| Versant Vantage II GP-GP, LLC | Other | 4.80% | 2,118,644 | 0 | 2,118,644 |
| Versant Vantage II GP, L.P. | Partnership | 4.80% | 2,118,644 | 0 | 2,118,644 |
| Versant Ventures IV, LLC | Other | 2.70% | 1,178,471 | 0 | 1,178,471 |
| Versant Venture Capital IV, L.P. | Partnership | 2.70% | 1,171,094 | 1,171,094 | 0 |
| Versant Ventures VI GP, L.P. | Partnership | 0.50% | 209,914 | 0 | 209,914 |
| Versant Venture Capital VI, L.P. | Partnership | 0.50% | 209,914 | 209,914 | 0 |
| Versant Ventures VI GP-GP, LLC | Other | 0.50% | 209,914 | 0 | 209,914 |
| Versant Side Fund IV, L.P. | Partnership | 0.00% | 7,377 | 7,377 | 0 |
Disclosure Items (1)
Security Title
Common Stock, par value $0.001 per share
Issuer Name
Tempest Therapeutics, Inc.
Issuer Address
2000 Sierra Point Parkway, Brisbane, CA, 94005